GRB2 and non-small cell lung carcinoma: Through the NSCLC-related pathway map, we discover that GRB2 can be acted as the trigger or initiation signal of the Raf/MEK/ERK pathway by PI3K-Akt signaling pathway and ErbB signaling pathway, which may be crucial for fucosterol in the treatment of NSCLC.